title: Plk1 phosphorylation of IRS2 prevents premature mitotic exit via AKT inactivation.
abstract: Insulin receptor substrate (IRS) proteins play important roles by acting as a platform in transducing signals from transmembrane receptors upon growth factor stimulation. Although tyrosine phosphorylation on IRS proteins plays critical roles in signal transduction, phosphorylation of IRS proteins on serine/threonine residues is believed to play various regulatory roles in IRS protein function. However, studies of serine/threonine phosphorylation of IRS proteins are very limited, especially for insulin receptor substrate 2 (IRS2), one member of the IRS protein family. In this study, we identify Polo-like kinase 1 (Plk1) as the responsible kinase for phosphorylation of IRS2 on two serine residues, Ser 556 and Ser 1098. Phosphorylation of IRS2 at these two serine residues by Plk1 prevents the activation of the PI3K pathway upon growth factor stimulation by inhibiting the binding between IRS2 and the PI3K pathway components and increasing the level of IRS2 protein degradation. Significantly, we show that IRS2 phosphorylation is cell cycle-regulated and that Plk1 phosphorylation of IRS2 prevents premature mitotic exit via AKT inactivation.
authors.affiliation: †Department of Biochemistry, Purdue University, West Lafayette, Indiana 47907, United States.
authors.forename: Long
authors.initials: L
authors.lastname: Chen
authors.affiliation: †Department of Biochemistry, Purdue University, West Lafayette, Indiana 47907, United States.
authors.forename: Zhiguo
authors.initials: Z
authors.lastname: Li
authors.affiliation: ‡Department of Dermatology, University of Wisconsin, Madison, Wisconsin 53706, United States.
authors.forename: Nihal
authors.initials: N
authors.lastname: Ahmad
authors.affiliation: †Department of Biochemistry, Purdue University, West Lafayette, Indiana 47907, United States.
authors.forename: Xiaoqi
authors.initials: X
authors.lastname: Liu
mesh_terms: D018797:Cell Cycle Proteins / Q000235:genetics / Q000378:metabolism*; D004789:Enzyme Activation / Q000502:physiology; D057809:HEK293 Cells; D006367:HeLa Cells; D006801:Humans; D055504:Insulin Receptor Substrate Proteins / Q000235:genetics / Q000378:metabolism*; D008938:Mitosis / Q000502:physiology*; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics / Q000378:metabolism; D010766:Phosphorylation / Q000502:physiology; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000378:metabolism*; D059748:Proteolysis; D011518:Proto-Oncogene Proteins / Q000235:genetics / Q000378:metabolism*; D051057:Proto-Oncogene Proteins c-akt / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*; D000097869:Polo-Like Kinase 1
chemical_list: D018797:Cell Cycle Proteins; D055504:Insulin Receptor Substrate Proteins; D019869:Phosphatidylinositol 3-Kinases; D017346:Protein Serine-Threonine Kinases; D011518:Proto-Oncogene Proteins; D051057:Proto-Oncogene Proteins c-akt; D000097869:Polo-Like Kinase 1; C526297:IRS2 protein, human
references.citation: J Biol Chem. 2005 Jan 21;280(3):2282-93
references.pmid: 15537654
references.citation: Am J Physiol Endocrinol Metab. 2011 May;300(5):E824-36
references.pmid: 21098738
references.citation: Clin Cancer Res. 2011 Oct 15;17(20):6459-66
references.pmid: 22003073
references.citation: Curr Biol. 2007 Feb 20;17(4):304-15
references.pmid: 17291761
references.citation: Curr Biol. 2002 Apr 2;12(7):R236-8
references.pmid: 11937037
references.citation: Annu Rev Pathol. 2009;4:127-50
references.pmid: 18767981
references.citation: Biochimie. 2005 Jan;87(1):99-109
references.pmid: 15733744
references.citation: Diabetologia. 2012 Oct;55(10):2565-82
references.pmid: 22869320
references.citation: Mol Cell Biol. 2014 Oct 1;34(19):3642-61
references.pmid: 25047839
references.citation: Cell Cycle. 2011 Jul 15;10(14):2255-62
references.pmid: 21654194
references.citation: J Membr Biol. 1999 May 1;169(1):1-12
references.pmid: 10227847
references.citation: Nat Rev Cancer. 2009 Aug;9(8):550-62
references.pmid: 19629070
references.citation: Arch Physiol Biochem. 2011 Jul;117(3):105-15
references.pmid: 21401320
references.citation: Mol Cell Proteomics. 2011 Nov;10(11):M111.008540
references.pmid: 21857030
references.citation: Nat Rev Drug Discov. 2010 Aug;9(8):643-60
references.pmid: 20671765
references.citation: Oncogene. 2005 Apr 18;24(17):2844-59
references.pmid: 15838519
references.citation: J Biol Chem. 2014 May 16;289(20):14066-74
references.pmid: 24706748
references.citation: Nat Commun. 2013;4:1882
references.pmid: 23695676
references.citation: Nat Rev Microbiol. 2008 Apr;6(4):266-75
references.pmid: 18311165
references.citation: Mol Cell Biochem. 1998 May;182(1-2):3-11
references.pmid: 9609109
references.citation: Nat Rev Cancer. 2006 Apr;6(4):321-30
references.pmid: 16557283
references.citation: Mutat Res Rev Mutat Res. 2014 Mar 12;:null
references.pmid: 24630986
references.citation: Leukemia. 2003 Mar;17(3):590-603
references.pmid: 12646949
references.citation: J Biol Chem. 2013 Jun 7;288(23):16403-15
references.pmid: 23615913
references.citation: Nature. 2014 Apr 24;508(7497):541-5
references.pmid: 24670654
references.citation: Endocr Dev. 2013;24:96-105
references.pmid: 23392098
references.citation: Physiol Rev. 2009 Jan;89(1):27-71
references.pmid: 19126754
references.citation: Adv Biol Regul. 2012 Sep;52(3):389-405
references.pmid: 22884032
references.citation: Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8672-6
references.pmid: 12077309
references.citation: Dev Cell. 2008 May;14(5):646-59
references.pmid: 18477449